Add a Comment By James Eastham, MD and Vincent Laudone, MD Friday, September 20, 2013 An earlier post about active surveillance as a management strategy for prostate cancer generated an engaged and meaningful discussion on this blog, especially about the risks of “doing nothing.” Here we take a closer look at the concept of risk. read more

When Do No Harm Means Do Nothing: Managing Risks

Scroll to Top